They arrive at Marib General Hospital every day in their hundreds: adults and children wounded by the ongoing […]
The pandemic has disproportionately affected people living in care homes, who accounted for an estimated 30% of all […]
Pfizer’s megablockbuster-to-be COVID pill Paxlovid scores FDA nod esagonowsky Wed, 12/22/2021 – 13:12
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators aliu Wed, 12/22/2021 – 09:18
Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir fkansteiner Wed, 12/22/2021 – 09:15
Despite myriad precautionary measures, virus-contaminated aerosols still pose a serious problem indoors. An invisible protective wall of UV-C […]
Research team from Chemnitz University of Technology, IFW Dresden and Max Planck Institute CBG presents a completely new […]
Calls for booster vaccinations in order to combat the rising cases brought about by winter and the recent […]
With authorisation, Pfizer’s oral antiviral candidate Paxlovid is an investigational SARS-CoV-2 protease inhibitor could be prescribed at the […]
Updated Date: Tue, 14 Dec 2021 00:00:00 EST